Kyoto University · Center for iPS Cell Research and Application

Research keywordshereditary spastic paraplegia・Charcot-Marie-Tooth disease・spinocerebellar ataxia・patient iPSCs・antisense oligonucleotides・neurodegeneration

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.1979 · Clinical science (London, England : 1979),
• Executive dysfunction in non-demented Parkinson's disease patients with hallucinationsACTA NEUROLOGICA SCANDINAVICA,
• Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.NPJ vaccines,
• Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus VectorsMOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT,

• Official profile